Fractyl Health, Inc.
GUTS Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 23, 2026
$1.08
KIRA · Stoqly’s AI analyst, in plain words
- Fractyl Health, Inc. had $0.0M of revenue in fiscal 2025, down 100.0% on the year before.
- Fractyl Health, Inc. lost $141M in fiscal 2025.
- Free cash flow was −$90.9M in fiscal 2025, — of revenue.
Market cap
$171M
P/E
—
Revenue
$0.0M
Net income
−$141M
Free cash flow
−$90.9M
Operating margin
—
Fractyl Health, Inc. in 30 seconds · fiscal 2025
Are sales growing?
−100.0%
No. Sales fell 100.0% last year.
Does it make a profit?
−$141M
No. It lost money last year.
How healthy are the accounts?
2 / 7
Weak. It passes 2 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Fractyl Health, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 24, 2026
- Legal name
- FRACTYL HEALTH, INC.
- CIK
- 0001572616
Fractyl Health, Inc. · GUTS
Results and finances
The last 3 fiscal years. Amounts in USD.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Sales and profit | |||
| Revenue | $0.1M | $0.1M | $0.0M |
| Revenue growth | — | −22.5% | −100.0% |
| Gross margin | 35.8% | 46.2% | — |
| Operating margin | −42,363.3% | −100,571.0% | — |
| Net income | −$77.1M | −$68.7M | −$141M |
| Net margin | −64,242.5% | −73,864.5% | — |
| Diluted EPS | −$45.29 | −$1.62 | −$1.86 |
| Cash | |||
| Cash from operations | −$42.8M | −$65.5M | −$90.3M |
| Capital expenditure | $0.4M | $1.8M | $0.6M |
| Free cash flow | −$43.2M | −$67.3M | −$90.9M |
| FCF margin | −35,985.0% | −72,350.5% | — |
| Share count change | — | 1,992.0% | 74.1% |
| Debt and strength | |||
| Cash and short-term investments | $33.2M | $67.5M | $81.5M |
| Shareholders' equity | −$325M | $28.4M | $9.5M |
| Current ratio | 3.2x | 3.6x | 4.8x |
| Returns and quality | |||
| Return on equity | — | — | −744.2% |
| Return on tangible equity | — | −247.8% | −1,490.3% |
| Piotroski F-score | — | 4 | 2 |
| Altman Z'' | −20.2 | −14.8 | −16.5 |
Insiders bought, 12 months
$0.2M
5 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Fractyl Health, Inc. · GUTS
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.08 a share, the company is worth $171M.
Source: SEC EDGAR XBRL filings (CIK 0001572616). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.